| Subcribe via RSS



Molecular Partners Gets $44M for its Rapid DARPin Scaffolds (BioWorld)

December 16th, 2009

Molecular Partners AG, which is commercializing a protein scaffold technology, raised CHF46 million (US$44.2 million) in a Series B financing round led by Essex Woodlands Health Ventures, taking its total investment raised in the past two and a half years to CHF64.5 million.

Original post by macular degeneration – Google News


(click on the author/publication link above to see full post)
This entry was posted on Wednesday, December 16th, 2009 at 9:33 am. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Comments are closed.

«
»